Khosla Ventures

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, a co-founder of Sun Microsystems. Based in Menlo Park, California, the firm manages over $5 billion and primarily invests in early-stage technology companies throughout the United States. Khosla Ventures provides capital, strategic advice, and venture assistance to entrepreneurs focused on breakthrough innovations across various sectors, including consumer technology, enterprise solutions, health, education, agriculture, and sustainable energy. The firm has a particular interest in high-risk, high-reward opportunities, often acting as a sole investor in "science or innovation experiments." Investment sizes typically range from $100,000 to over $20 million, allowing Khosla Ventures to support both traditional ventures and unconventional projects.

Bruce Armstrong

Operating Partner

Irene Au

Angel

Ryno Blignaut

Operating Partner

Alice Brooks

Partner

Peter Buckland

Partner, Managing Director and COO

Benny Buller

Investment Professional

Brian Byun

Operating Partner

Catherine Casuga

Operating Partner

Kanu Gulati

Partner

Emmanuel T. Hernandez

Operating Partner

Judy Huang

Operating Partner

Keith Janosky

Chief Financial Officer and Head of Investor Relations

Jun Jeon

Principal

Samir Kaul

Founding Partner & Managing Director

Paul Kirincich

Operating Partner

Alexander A. Morgan

Partner

Alexander Morgan Ph.D

Partner

Hesam Motlagh

Chief of Staff

Keith Rabois

Managing Director

Nikita Shamgunov

Partner & Investor

Sven Strohband Ph.D

Managing Director

Rajesh Swaminathan

Partner

Adina Tecklu

Partner

Sandhya Venkatachalam

Partner

David Weiden

Founding Partner and Managing Director

Ece Wyrick

Principal

Past deals in Computer Vision

Mojo Vision

Series C in 2023
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today's mobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Mimica Automation

Series A in 2021
Mimica Automation Limited develops a software based on machine learning algorithms that observes the user for a few weeks; derives the intent behind the clicks and keystrokes; and generates the automation automatically. Its mapper, is an automated process mapping solution which gather data from the employee’s computer and records their process for 2-3 weeks, the machine learning algorithms then clean, analyze, and merge the recordings into a single process map. The company was founded in 2018 and is based in London, United Kingdom.

Quadrant Eye

Seed Round in 2021
QE is building remote eye exams. Our mission to is take all of eye care remote.

Akasha Imaging

Series A in 2020
Akasha Imaging provides deep imaging solutions combining computational imaging and deep learning to create computer vision systems. The company was founded in 2019 and is based in Palo Alto, California.

Caption Health

Series B in 2020
Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings.

Mojo Vision

Series B in 2020
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today's mobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

HeartVista.ai

Series A in 2020
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Using AI to control the scanner minimizes the need for breath-holds, making MRI exams available for a broader base of patients and conditions.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Compound Eye

Series A in 2018
Compound Eye Inc. develops 3D vision software tools for autonomous machines. The company was incorporated in 2015 and is based in San Francisco, California.

Mojo Vision

Series A in 2018
Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today's mobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Artrendex

Venture Round in 2018
Artrendex, Inc., founded in 2016 and located in East Windsor, New Jersey, offers artificial intelligence solutions designed to assist artists, galleries, and collectors in realizing their goals. The company specializes in quantifying aesthetic concepts, traditionally viewed as subjective, through advanced visual analytics. Its innovative models can predict style changes and trends based on historical data, addressing the needs of a substantial art market valued at over $64 billion. As much of this market consists of art purchased as an investment, Artrendex provides essential data-analytics tools that help assess the potential value of artworks.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.

vicarious

Series C in 2017
Vicarious is an artificial intelligence company founded in 2010 by Dr. Dileep George and D. Scott Phoenix, headquartered in San Francisco, California. The company focuses on developing general intelligence for robots by leveraging the computational principles of the human brain. Vicarious aims to tackle significant challenges in the field of AI, fostering a culture that values intellectual curiosity, collaboration, and passion among its team members.

MDalgorithms

Seed Round in 2017
MDAlgorithms uses smart algorithms, computer vision, and AI to provide real time mobile tools for people with health disorders. The company's mission is to disrupt the old physician centric medical system and put the patient in the center.

Syllable

Seed Round in 2017
Syllable is a developer of a text and voice-based platform designed to enhance communication between healthcare providers and patients. By leveraging artificial intelligence, the platform facilitates interactions regarding primary care, specialty referrals, vaccinations, and general practice information. This technology enables patients to access healthcare information and guidance beyond traditional clinical settings, improving overall communication and patient engagement in their healthcare journeys.

Caption Health

Series A in 2016
Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings.

Zebra Medical Vision

Series B in 2016
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.

Zebra Medical Vision

Seed Round in 2015
Zebra Medical Vision Ltd. is an Israeli company founded in 2014 that specializes in developing an imaging analytics platform aimed at enhancing healthcare delivery. The platform provides a comprehensive suite of imaging research solutions for clinicians, advanced machine learning and computer vision diagnostic algorithms for developers, and risk management tools for healthcare providers. By offering access to a vast repository of anonymized clinical records, Zebra Medical Vision supports researchers in accelerating the development of decision support tools and improving diagnostic accuracy. The company collaborates with various partners, including USARAD Holdings and TELUS Ventures, to leverage its network of over 1,100 hospitals and healthcare providers. This collaboration fosters innovation and enhances patient care through the application of advanced analytics and automated clinical insights, positioning Zebra Medical Vision as a leader in the integration of AI and machine learning in medical imaging.

Caption Health

Seed Round in 2015
Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings.

MetaMind

Venture Round in 2014
Starting with automated image recognition — MetaMind was founded to explore positive and impactful applications for artificial intelligence. We believe AI is only beneficial when it works to simplify the complexity of our daily lives. It is this notion which inspires us to produce technology which is reliable, trustworthy, and easy to use.

vicarious

Series B in 2014
Vicarious is an artificial intelligence company founded in 2010 by Dr. Dileep George and D. Scott Phoenix, headquartered in San Francisco, California. The company focuses on developing general intelligence for robots by leveraging the computational principles of the human brain. Vicarious aims to tackle significant challenges in the field of AI, fostering a culture that values intellectual curiosity, collaboration, and passion among its team members.

vicarious

Series B in 2014
Vicarious is an artificial intelligence company founded in 2010 by Dr. Dileep George and D. Scott Phoenix, headquartered in San Francisco, California. The company focuses on developing general intelligence for robots by leveraging the computational principles of the human brain. Vicarious aims to tackle significant challenges in the field of AI, fostering a culture that values intellectual curiosity, collaboration, and passion among its team members.

Berkshire Grey

Series A in 2013
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

HeartVista.ai

Seed Round in 2012
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Using AI to control the scanner minimizes the need for breath-holds, making MRI exams available for a broader base of patients and conditions.